Orally Active GPIIb/IIIa Antagonists. Synthesis and Biological Activities of Masked Amidines as Prodrugs of 2-[(3S)-4-[(2S)-2-(4-Amidinobenzoylamino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic Acid.
- 1 January 2001
- journal article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 49 (3), 268-277
- https://doi.org/10.1248/cpb.49.268
Abstract
To improve the in vivo potency of the potent GPIIb/IIIa antagonist 2-[(3S)-4-[(2S)-2-(4-amidinobenzoylamino)-3-(4-methoxyphenyl)propanoyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyljacetic acid (4), the amidino group was converted to an oxadiazole ring, thiadiazole ring or substituted amidoxime group. These groups were expected to be metabolized to an amidino group in vivo. The compounds synthesized were evaluated for their potency to inhibit the ex vivo adenosine 5'-diphosphate (ADP)-induced aggregation of guinea pig platelets. Among the compounds examined, the methoxycarbonyloxyamidine 8a exhibited the most potent ex vivo inhibitory activity with a fast onset and prolonged duration of action after oral administration.Keywords
This publication has 24 references indexed in Scilit:
- Novel Non-Peptide Fibrinogen Receptor Antagonists. 1. Synthesis and Glycoprotein IIb-IIIa Antagonistic Activities of 1,3,4-Trisubstituted 2-Oxopiperazine Derivatives Incorporating Side-Chain Functions of the RGDF PeptideJournal of Medicinal Chemistry, 1998
- Anti-pneumocystis activity of bis-amidoximes and bis-o-alkylamidoximes prodrugsBioorganic & Medicinal Chemistry Letters, 1996
- New antithrombotic RGD-mimetics with high bioavailabilityBioorganic & Medicinal Chemistry Letters, 1996
- Synthesis and Angiotensin II Receptor Antagonistic Activities of Benzimidazole Derivatives Bearing Acidic Heterocycles as Novel Tetrazole BioisosteresJournal of Medicinal Chemistry, 1996
- A new class of angiotensin II receptor antagonists with a novel acidic bioisostereBioorganic & Medicinal Chemistry Letters, 1995
- Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor AntagonistsJournal of Medicinal Chemistry, 1995
- Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-AspJournal of Medicinal Chemistry, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitroJournal of Medicinal Chemistry, 1991
- Ueber Benzenylamidoxim‐p‐carbonsäureEuropean Journal of Inorganic Chemistry, 1885